Aclasta (zoledronic): Reviews and patient testimonials
Back to the list of medications
Medication indications
Aclasta 5 mg solution for infusion
Treatment of osteoporosis
• in post-menopausal women
• in adult men
at increased risk of fracture, including those with a recent low-trauma hip fracture.
Treatment of osteoporosis associated with long-term systemic glucocorticoid therapy
• in post-menopausal women
• in adult men
at increased risk of fracture.
Treatment of Paget's disease of the bone in adults.
Route of administration: Injectable
Molecule: zoledronic
Patients' opinions on Aclasta
Conditions related to this medication
Fact sheet
See the fact sheet
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.